We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

LabTube TV meets Elizabeth Admirand, Epizyme

Video   Nov 01, 2017

 

Elizabeth Admirand, Principal Research Scientist, discusses how entering the clinical stage drove changes to Epizyme's sample management systems for compounds and biologics. She reviews their reasons for choosing Titian's Mosaic software and discusses how Epizyme implemented it to achieve accurate inventory for their compound management samples and to start tracking their biologics.

 
More Information

Request Information

 
 
 

Recommended Videos

The Advantages of Machine Learning and Artificial Intelligence in the Drug Discovery Process

Video

Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.

WATCH NOW

How Deep Learning Architectures Have Improved Chemical Reaction Prediction

Video

Dr Ola Engkvist, AstraZeneca, explains how deep learning architectures improve chemical reaction prediction.

WATCH NOW

Applying Deep Learning Architectures to de novo Molecular Drug Design

Video

Dr Ola Engkvist, AstraZeneca, outlines how deep learning architectures are being applied to drug discovery.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE